Related Experiment Video
Updated: Dec 23, 2025
04:38
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
16.3K
An update on treatment options for primary sclerosing cholangitis
Shahrokh Iravani1,2, Arash Dooghaie-Moghadam3, Niloofar Razavi-Khorasani3
1Research Center for Cancer Screening and Epidemiology, AJA University of Medical Sciences, Tehran, Iran.
Gastroenterology and Hepatology From Bed to Bench
|April 21, 2020
Summary
Primary sclerosing cholangitis (PSC) is a chronic liver disease with no cure. This review examines current treatments for PSC, focusing on managing inflammation and disease progression.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary tree strictures.
- PSC can lead to serious complications such as liver cirrhosis and cholangiocarcinoma.
- The exact etiology of PSC is unknown, but immune-mediated mechanisms are strongly implicated.
Purpose of the Study:
- To review current treatment options for patients diagnosed with primary sclerosing cholangitis.
- To provide an overview of therapies targeting the inflammatory aspects of PSC.
- To highlight the lack of consensus on optimal PSC treatment strategies.
Main Methods:
- Literature review of existing studies on primary sclerosing cholangitis treatments.
- Analysis of treatment modalities focusing on inflammation and disease progression.
- Synthesis of current evidence regarding therapeutic options for PSC.
Main Results:
- Various treatment modalities exist for PSC, primarily addressing inflammation.
- No definitive consensus has been reached regarding the most effective treatment for PSC.
- Current treatments aim to manage symptoms and slow disease progression.
Conclusions:
- Effective management of primary sclerosing cholangitis remains a significant clinical challenge.
- Further research is needed to establish consensus on optimal treatment strategies for PSC.
- Addressing immune-mediated mechanisms is crucial for developing future PSC therapies.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
227
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
227
01:17Chronic Bowel Disorders: Introduction
696
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
696
01:28Esophageal Varices-II: Clinical Features and Management
299
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
299
01:21Inflammatory Bowel Disease V: Surgical Management
359
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
359
01:26Peptic Ulcer Disease IV: Management
350
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
350
01:27Peripheral Artery Disease III: Interprofessional Care
178
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
178